Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Hartono C, Chung M, Kuo SF, Seshan SV, Muthukumar T. Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy. J Nephrol. 2014;27(1):103-6.

Loo FL, Halligan AM, Port JL, Hoda RS. The emerging technique of electromagnetic navigation bronchoscopy-guided fine-needle aspiration of peripheral lung lesions: promising results in 50 lesions. Cancer Cytopathol. 2014;122(3):191-9.

Lonze BE, Zachary AA, Magro CM, Desai NM, Orandi BJ, Dagher NN, et al. Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation. Am J Transplant. 2014;14(2):459-65.

Ozerdem U, Hoda SA. Swiss cheese disease of the breast: macroscopic appearance of microscopic slides offers a diagnostic clue. Int J Surg Pathol. 2014;22(1):66-7.

Velu PD, Mullen T, Noh E, Valdivia MC, Poizner H, Baram Y, et al. Effect of visual feedback on the occipital-parietal-motor network in Parkinson's disease with freezing of gait. Front Neurol. 2014;4:209.

Elwood H, Kim J, Yemelyanova A, Ronnett BM, Taube JM. Basal cell carcinomas of the vulva: high-risk human papillomavirus DNA detection, p16 and BerEP4 expression. Am J Surg Pathol. 2014;38(4):542-7.

Bishop JA, Yonescu R, Batista D, Yemelyanova A, Ha PK, Westra WH. Mucoepidermoid carcinoma does not harbor transcriptionally active high risk human papillomavirus even in the absence of the MAML2 translocation. Head Neck Pathol. 2014;8(3):298-302.

Yigit N, Geyer JT. Bone marrow metastasis of prostatic adenocarcinoma with post-treatment foamy-like changes: A diagnostic pitfall. Can Urol Assoc J. 2014;8(11-12):E941-3.

Allmendinger AM, Mallery RM, Magro CM, Wang N, Egan RA, Samuels MA, et al. Cauda equina involvement in Susac's syndrome. J Neurol Sci. 2014;337(1-2):91-6.

Taplin M-, Montgomery B, Logothetis CJ, Bubley GJ, Richie JP, Dalkin BL, et al. Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study. J Clin Oncol. 2014;32(33):3705-15.